Catalyst Wire Dossier Catalyst Wire Dossier

Ulodesine

ulodesine · BioCryst Pharmaceuticals
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Ulodesine, covering 2013-11-20 to 2013-11-20. Get the full timeline:

Most recent: Clinical Trial Update: A Randomized, Double-Blind, Dose-Response Study of the Safety and Uric Acid Effects of Oral Ulodesine Added to Allopurinol in Subjects With Gout and Concomitant Moderate Renal Insufficiency [Phase 2]

See pricing